Acquisition of Laprolan B.V. from Fornix BioSciences N.V. (Tables)

9 Months Ended

Jun. 30, 2012

Acquisition of Laprolan B.V. from Fornix BioSciences N.V.

Summary of fair values of assets and liabilities acquired at the date of acquisition

Current assets	$	3,212,000
Property and equipment	1,831,000
Intangible assets	10,545,000
Total assets acquired	$	15,588,000
Current liabilities	$	824,000
Long term liabilities	877,000
Total liabilities assumed	$	1,701,000

Schedule of pro forma unaudited results of operations

	Three Months Ended		Nine Months Ended
	June 30, 2011		June 30, 2011
	(pro forma)		(pro forma)
Net sales	$	14,281	$	40,794
Net income (loss)	29		(596		)
Per share data:
Net loss per share - basic	$	0.00	$	(0.05	)
Net loss per share - diluted	$	0.00	$	(0.05	)